Haematological Indicators of Response to Erythropoietin Therapy in Chronic Renal Failure Patients on Haemodialysis: Impact of Angiotensin-Converting Enzyme rs4343 Gene Polymorphism
Abdulrahman Hamdan Almaeen,1 Gomaa Mostafa-Hedeab2,3 1Pathology Department, Medical College, Jouf University, Sakaka, Kingdom of Saudi Arabia; 2Pharmacology Department, Health Sciences Research Unit, Medical College, Jouf University, Sakaka, Kingdom of Saudi Arabia; 3Pharmacology Department, Faculty...
Main Authors: | Hamdan Almaeen A, Mostafa-Hedeab G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-08-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/haematological-indicators-of-response-to-erythropoietin-therapy-in-chr-peer-reviewed-fulltext-article-PGPM |
Similar Items
-
The assessment of native erythropoietin and antibodies to recombinant erythropoietin in haemodialysis patients
by: Benjamin, Sherilene Cheryl
Published: (2008) -
The assessment of native erythropoietin and antibodies to recombinant erythropoietin in haemodialysis patients
by: Benjamin, Sherilene Cheryl
Published: (2008) -
Gender differences in dose of erythropoietin to maintain hemoglobin target in hemodialysis patients
by: J A Coronado Daza, et al.
Published: (2019-01-01) -
ACE gene polymorphism and its association with serum erythropoietin and hemoglobin ‎in Iraqi hemodialysis patients
by: Al-Radeef MY, et al.
Published: (2019-07-01) -
The Effects of Erythropoietin in the Management of Anemia of Chronic Renal Failure in Patients on Hemodialysis
by: M Rahimian, et al.
Published: (2005-04-01)